Gainers
- Broadwind, Inc. BWEN rose 68.1% to $3.80 in pre-market trading after the company reported transformational two-year, $175 million wind tower order with global wind turbine manufacturer.
- Hepion Pharmaceuticals, Inc. HEPA shares rose 45.2% to $0.6671 in pre-market trading after the company announced presentation of preclinical study highlighting anti-cancer activity of rencofilstat in combination with proteosome inhibitors.
- Party City Holdco Inc. PRTY rose 37.5% to $0.6209 in pre-market trading. Party City Holdco shares jumped 118% on Tuesday following an Axios report suggesting The Franchise Group could be looking at acquiring the company.
- Biora Therapeutics, Inc. BIOR shares rose 32.2% to $7.14 in pre-market trading after jumping 155% on Tuesday. Biora Therapeutics recently received pre-IND feedback from the FDA and issued an update on key programs for 2023.
- Jaguar Health, Inc. JAGX rose 32.2% to $0.1335 in pre-market trading after gaining around 12% on Tuesday.
- Laser Photonics Corporation LASE rose 29.3% to $3.27 in pre-market trading. Laser Photonics said on Jan. 9, that the company’s board authorized initiation of share repurchase program to purchase up to 2 million shares of common stock.
- Bed Bath & Beyond Inc. BBBY rose 22.5% to $2.54 in pre-market trading after adding more than 27% during regular market hours on Tuesday. According to a Wall Street Journal report citing people familiar with the matter, Bed Bath & Beyond has brought on consulting firm AlixPartners as its new restructuring advisor. The company reported a quarterly adjusted net loss of $3.65 per share, which missed estimates for a loss of $2.11 per share.
- Esports Entertainment Group, Inc. GMBL rose 22.3% to $0.0999 in pre-market trading after gaining over 7% on Tuesday.
- AIM ImmunoTech Inc. AIM shares rose 21.9% to $0.64 in pre-market trading after gaining 7% on Tuesday.
- ProKidney Corp. PROK rose 19.9% to $9.20 in pre-market trading. ProKidney announced publication of trial design for Phase 2 multicenter clinical trial of REACT for late stage 4 diabetes-related chronic kidney disease.
Losers
- Cybin Inc. CYBN fell 17.3% to $0.4650 in pre-market trading after gaining around 14% on Tuesday.
- FOXO Technologies Inc. FOXO shares fell 12.7% to $0.2970 in pre-market trading after adding 6% on Tuesday.
- Argo Blockchain plc ARBK fell 11.8% to $1.12 in pre-market trading after the company issued operational update for December 2022.
- Treasure Global Inc. TGL fell 9.5% to $1.53 in pre-market. Treasure Global, on Tuesday, signed a MOU in Malaysia with Boost to discuss a new partnership..
- Lightning eMotors, Inc. ZEV fell 9.1% to $0.4847 in pre-market trading. Lightning eMotors said it sees Q4 revenue of $4 million, versus analysts’ estimates of $15.03 million.
- G Medical Innovations Holdings Ltd GMVD fell 8.8% to $3.28 in pre-market trading after dropping 18% on Tuesday.
- Apexigen, Inc. APGN fell 8.6% to $1.71 in pre-market trading.
- Versus Systems Inc. VS fell 8.1% to $0.6801 in pre-market trading after surging 22% on Tuesday.
- Panbela Therapeutics, Inc. PBLA fell 7.5% to $0.0956 in pre-market trading after climbing 28% on Tuesday.
- Satixfy Communications Ltd. SATX shares fell 7.1% to $6.45 in pre-market trading after gaining around 8% on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in